Scale into SPCX via three disciplined tranches post-9/15 SPCX lesson; Overweight captures constructive bias without full Buy conviction
The 9/15 SPCX failure (-5.6% alpha from Underweight) and 9/10 SPCX success (+1.2% alpha from Hold) define operating discipline: participate in asymmetric catalyst through disciplined tranches, do NOT under-commit to bearishness when institutional floor has demonstrably absorbed prior stress tests ($108-130 zone absorbed Nvidia $21B 13F, Harvard $2.2B, Alphabet $94B, MS $300 PT), and let September 22 catalyst force magnitude reassessment on 10-day time-stop. Bear concerns (85x P/S, death cross at $134.49/$142.45, declining volume 519M to 79-121M, $7.60 ATR, fat-middle Flight 14 outcomes) are real but already discounted in Overweight sizing—not enough for Underweight per 9/15 lesson but enough for magnitude discipline. Target weight 1.5-2.0% portfolio.
| Position | Action |
|---|---|
| Tranche 1 (40% of target) | 0.6-0.8% of portfolio at $150-152 entry (Aggressive); 0.3-0.4% (Conservative); 0.4-0.5% (Neutral) |
| Tranche 2 (30% of target) | At 10 EMA pullback ($147.24) |
| Tranche 3 (30% of target) | Post-Flight 14 repositioning |
| If messy middle materializes at Flight 14 | Tranche 3 should NOT deploy; re-anchor residual to tighter stop or trim by 25-30% |
| Post-Flight 14 within 48 hours (messy middle scenario) | Reduce Tranche 1 by half regardless of stop triggers |
SPCX presents a rare three-way convergence of bullish technicals (golden cross forming, RSI neutral at 57.34, price above all MAs), accelerating fundamentals (92% YoY revenue growth, +1,410bps margin expansion, +$2.42B OCF), and structural catalysts (Starship Flight 14, Pentagon Starshield, AI infrastructure reframe), making any pullback to the 10 EMA at $147.24 a compelling long entry with $170+ target.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | $147.24 | bullish |
| close_50_sma | $134.49 | bullish |
| close_200_sma | $142.45 | bullish |
| macd | 3.78 (Signal: 3.71, Histogram: 0.07) | bullish |
| rsi | 57.34 | neutral |
| boll_ub | $155.04 | neutral |
| boll_lb | $132.24 | neutral |
| atr | $7.60 | neutral |
| vwma_20 | $146.95 | bullish |
| boll_middle_20sma | $143.64 | bullish |
Support: 147.24 · 142.45 · 132.24 · 134.49 | Resistance: 155.04 · 153.47 · 170.86
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 10 EMA pullback to $147.24
Then: Deploy 30% of target position
Revenue growth is accelerating into IPO, not decelerating, justifying premium valuation
EV: $170+ · concedes: Forward P/E is 87x on TTM earnings; Prior net loss $8.9B, capex burn $40B+ annually; P/B 15.6x elevated; P/S 85x premium to traditional aerospace peers; Insider supply risk from future secondaries is speculative but real concern; Musk political risk is headline risk, not fundamental risk (though government contract sensitivity exists)
SPCX at $150 is a trap, not a triumph — the technical setup shows a death cross structure with bearish RSI divergence and distribution volume patterns, while fundamentals reveal operating income turned negative despite gross margin expansion, R&D exploded to 46% of revenue, and capex consumes 248% of annualized revenue. The $100B cash position was funded by massive IPO dilution, the Starship catalyst is already priced in at 40% via Polymarket, and the 85x P/S multiple offers no margin of safety.
EV: -$6 to -$15.88 (target $135-142 vs current $150.88; 30-50% downside over 6-12 months from multiple compression) · concedes: 33-35% underlying revenue growth is still excellent even if below 92% headline; Starlink is the best business in the portfolio; $100B cash provides 18-24 months runway; Gross margin expansion to 55.3% is real progress; Starship reusability thesis has 40% probability on Polymarket
→ vs conservative: Death cross at $142.45 versus $134.49 is mathematically lagging noise anchored to June blow-off top, not structural bearish signal; 50 SMA rising rapidly and golden cross is forming; VWMA at $146.95 confirms accumulation over distribution; MACD freshly positive at 0.07
→ vs neutral: $142 pullback entry will never materialize given event-driven demand; 85x P/S meaningless standalone metric when revenue growing 92% YoY with gross margins expanding from 41% to 55%; P/E of 87x irrelevant during steepest part of growth curve; $100 billion cash eliminates forced dilution risk
→ vs conservative: Calling distribution in a name where 39% rally in six weeks, MACD positive at 0.07, RSI at 57 with room to run, and VWMA confirming accumulation represents anchoring to a lagging indicator that will flip bullish soon
→ vs neutral: Waiting for FCF inflection and sustained pullback to 200-day MA at $142 means opting out of binary catalyst with asymmetric upside; Polymarket at 40% for full reusability before 2027 is market pricing real probability of step-change in launch economics
→ vs conservative: Execution risk is real but position sizing at 1.5 to 2 percent target weight with stop at $135 is disciplined risk management, not recklessness; upside multiples of downside if catalyst delivers
SPCX exhibits constructively bullish technical posture with fresh momentum signals, having recovered +39% from the $108.27 July trough to the current $150.88 close. Price is pressing against near-term Bollinger resistance at $155.04 with RSI at 57.34 (neutral-bullish, no overbought readings), while MACD shows a fresh bullish crossover with histogram at 0.07. The 50 SMA ($134.49) remains below the 200 SMA ($142.45) — an unusual ordering with a potential golden cross setup ~$8 away — making momentum tools the more reliable signal sources until that crossover completes.
Market Cap
$1.989 Trillion
52-Week High
$225.64
52-Week Low
$104.83
Current Price
~$151-160
50-Day Moving Average
$134.46
200-Day Moving Average
$142.32
Forward P/E
86.56x
Price to Book
15.63x
EPS (TTM)
-$1.10
Forward EPS
$1.74
Book Value/Share
$9.66
Revenue FY2023
$10.39 Billion
Revenue FY2024
$14.02 Billion
Revenue FY2025
$18.67 Billion
Revenue Q2 2026
$7.814 Billion
Gross Margin FY2023
41.2%
Gross Margin FY2024
42.9%
Gross Margin FY2025
49.4%
Gross Margin Q2 2026
55.3%
R&D Expense FY2023
$2.11 Billion
R&D Expense FY2024
$3.46 Billion
R&D Expense FY2025
$8.64 Billion
R&D as % of Revenue
46%
Operating Income FY2023
$0.51 Billion
Operating Income FY2024
$0.74 Billion
Operating Income FY2025
-$2.07 Billion
Net Income FY2023
-$4.63 Billion
Net Income FY2024
$0.79 Billion
Net Income FY2025
-$4.94 Billion
Net Income TTM
-$8.9 Billion
Net Income Q1 2026
-$4.276 Billion
Profit Margin TTM
-35.7%
EBITDA FY2023
-$0.66 Billion
EBITDA FY2024
$5.65 Billion
EBITDA FY2025
$4.43 Billion
Cash & ST Investments Q2 2026
$100.01 Billion
Total Current Assets Q2 2026
$108.05 Billion
Net PP&E Q2 2026
$66.85 Billion
Total Assets Q2 2026
$192.77 Billion
Total Debt Q2 2026
$39.71 Billion
Long-Term Debt Q2 2026
$36.84 Billion
Stockholders' Equity Q2 2026
$127.22 Billion
Preferred Stock Equity Q2 2026
$0
Current Ratio Q2 2026
5.11x
Historical D/E Ratio
31.2x
Construction in Progress
$12.5 Billion
Operating Cash Flow FY2023
$4.52 Billion
Operating Cash Flow FY2024
$5.78 Billion
Operating Cash Flow FY2025
$6.79 Billion
Operating Cash Flow Q2 2026
$2.42 Billion
Capex FY2023
-$4.42 Billion
Capex FY2024
-$11.16 Billion
Capex FY2025
-$20.74 Billion
Capex Q2 2026
-$19.24 Billion
Free Cash Flow FY2023
+$0.11 Billion
Free Cash Flow FY2024
-$5.39 Billion
Free Cash Flow FY2025
-$14.12 Billion
Free Cash Flow Q2 2026
-$16.82 Billion
Stock Issued Q2 2026
$85.68 Billion
Ending Cash Q2 2026
$94.35 Billion
Strengths
Concerns
SPCX is a hyper-growth aerospace and space transportation company with $1.989T market cap, currently loss-making (TTM -$8.9B net loss) but generating strong revenue momentum (Q2 2026 +92% YoY) driven by Starlink subscriber ramp and commercial launch cadence, while gross margins expand toward 55%. The stock trades at extreme valuations (86.56x forward P/E, 15.63x P/B) reflecting market expectations for Starship-enabled future markets and Starlink monetization, but faces significant cash burn (~$40B+ annual capex) and execution risk given the elevated valuation multiple. Post-IPO balance sheet is fortified with $100B cash, providing runway for aggressive growth investment without near-term dilution needs.
Macro: Hawkish. Fed hiked at September meeting (95% probability of zero rate cuts in 2026); bond yields rose; equities sold off (Dow –600). Jamie Dimon flagged inflation as unfinished business. US recession odds at 12% by YE 2026 (+4pp wk). Risk-off cross-asset backdrop (crypto volatility elevated after CLARITY Act failure). Direct FRED macro data unavailable; macro commentary grounded in news wire and Polymarket prediction markets.